The prognostic value of pretreatment Glasgow Prognostic Score in patients with esophageal cancer: a meta-analysis

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6(1):149–163. doi:10.2217/fon.09.13620021215
   PubMed Web of Science ®Google Scholar
• Nakamura M, Iwahashi M, Nakamori M, et al. New prognostic score for the survival of patients with esophageal squamous cell carcinoma. Surg Today. 2014;44(5):875–883. doi:10.1007/s00595-013-0628-z23784105
   PubMed Web of Science ®Google Scholar
• Liu JS, Huang Y, Yang X, Feng JF. A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma. Am J Cancer Res. 2015;5(7):2180–2189.26328248
   PubMed Web of Science ®Google Scholar
• Liu DQ, Li FF, Jia WH. Cumulative scores based on plasma D-dimer and serum albumin levels predict survival in esophageal squamous cell carcinoma patients treated with transthoracic esophagectomy. Chin J Cancer. 2016;11(35):11. doi:10.1186/s40880-015-0062-2
   Google Scholar
• Okuno T, Wakabayashi M, Kato K, et al. Esophageal stenosis and the Glasgow prognostic score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303). Int J Clin Oncol. 2017;22(6):1042–1049. doi:10.1007/s10147-017-1154-628717855
   PubMed Web of Science ®Google Scholar
• Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89(6):1028–1030. doi:10.1038/sj.bjc.660124212966420
   PubMed Web of Science ®Google Scholar
• Nozoe T, Iguchi T, Egashira A, Adachi E, Matsukuma A, Ezaki T. Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma. Am J Surg. 2011;201(2):186–191. doi:10.1016/j.amjsurg.2010.01.03020832047
   PubMed Web of Science ®Google Scholar
• Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T. Impact of an inflammation-based prognostic system on patients undergoing surgery for hepatocellular carcinoma: a retrospective study of 398 Japanese patients. Am J Surg. 2012;203(1):101–106. doi:10.1016/j.amjsurg.2010.09.03021429472
   PubMed Web of Science ®Google Scholar
• Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg. 2007;246(6):1047–1051. doi:10.1097/SLA.0b013e318145417118043109
   PubMed Web of Science ®Google Scholar
• Vashist YK, Loos J, Dedow J, et al. Glasgow prognostic score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer. Ann Surg Oncol. 2011;18(4):1130–1138. doi:10.1245/s10434-010-1383-720981494
   PubMed Web of Science ®Google Scholar
• Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;7(8):16. doi:10.1186/1745-6215-8-16
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-nanalyses. BMJ. 2003;327(7414):557–560. doi:10.1136/bmj.327.7414.55712958120
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. Trim and fll: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455–463. doi:10.1111/j.0006-341X.2000.00455.x10877304
   PubMed Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi:10.1186/2046-4053-4-125554246
   PubMed Web of Science ®Google Scholar
• Wang CY, Lee TF, Fang CH, Chou JH. Fuzzy logic-based prognostic score for outcome prediction in esophageal cancer. IEEE Trans Inf Technol Biomed. 2012;16(6):1224–1230. doi:10.1109/TITB.2012.221137422875252
   PubMedGoogle Scholar
• Kimura J, Kunisaki C, Makino H, et al. Evaluation of the Glasgow prognostic score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer. Dis Esophagus. 2016;29(8):1071–1080. doi:10.1111/dote.1242026471766
   PubMed Web of Science ®Google Scholar
• Hirahara N, Matsubara T, Hayashi H, Takai K, Fujii Y, Tajima Y. Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer. Eur J Surg Oncol. 2015;41(10):1308–1315. doi:10.1016/j.ejso.2015.07.00826235238
   PubMed Web of Science ®Google Scholar
• Lindenmann J, Fink-Neuboeck N, Avian A, et al. Preoperative Glasgow prognostic score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy. Eur J Surg Oncol. 2017;43(2):445–453. doi:10.1016/j.ejso.2016.10.01527839896
   PubMed Web of Science ®Google Scholar
• Feng JF, Zhao Q, Chen QX. Prognostic significance of Glasgow prognostic score in patients undergoing esophagectomy for esophageal squamous cell carcinoma. Saudi J Gastroenterol. 2014;20(1):48–53. doi:10.4103/1319-3767.12631924496158
   PubMed Web of Science ®Google Scholar
• Toyokawa T, Kubo N, Tamura T, et al. The pretreatment Controlling nutritional status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study. BMC Cancer. 2016;16:722. doi:10.1186/s12885-016-2696-027599460
   PubMed Web of Science ®Google Scholar
• Xu XL, Yu HQ, Hu W, Song Q, Mao WM. A novel inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS One. 2015;10(9):e0138657. doi:10.1371/journal.pone.013865726390126
   PubMed Web of Science ®Google Scholar
• Lindenmann J, Fink-Neuboeck N, Koesslbacher M, et al. The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment. J Surg Oncol. 2014;110(6):645–650. doi:10.1002/jso.2371124975677
   PubMed Web of Science ®Google Scholar
• Ohira M, Kubo N, Masuda G, et al. Glasgow prognostic score as a prognostic clinical marker in T4 esophageal squamous cell carcinoma. Anticancer Res. 2015;35(9):4897–4901.26254385
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Teruya M, Kishiki T, et al. Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma. Surgery. 2008;144(5):729–735. doi:10.1016/j.surg.2008.08.01519081014
   PubMed Web of Science ®Google Scholar
• Matsuda S, Takeuchi H, Kawakubo H, et al. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score. Ann Surg Oncol. 2015;22(1):302–310. doi:10.1245/s10434-014-3857-524952029
   PubMed Web of Science ®Google Scholar
• Ma Q, Liu W, Jia R, et al. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels. World J Surg Oncol. 2016;14:141. doi:10.1186/s12957-016-0878-527151090
   PubMed Web of Science ®Google Scholar
• Jomrich G, Paireder M, Gleiss A, Kristo I, Harpain L, Schoppmann SF. Comparison of inflammation-based prognostic scores in a cohort of patients with resectable esophageal cancer. Gastroenterol Res Pract. 2017;2017:1678584.28740506
   PubMed Web of Science ®Google Scholar
• Tan Z, Zhang M, Han Q, et al. A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the fibrinogen/albumin ratio. J Cancer. 2017;8(6):1025–1029. doi:10.7150/jca.1649128529615
   PubMed Web of Science ®Google Scholar
• Yu X, Wen Y, Lin Y, et al. The value of preoperative Glasgow prognostic score and the C-reactive protein to albumin ratio as prognostic factors for long-term survival in pathological T1N0 esophageal squamous cell carcinoma. J Cancer. 2018;9(5):807–815. doi:10.7150/jca.2275529581759
   PubMed Web of Science ®Google Scholar
• Kunizaki M, Tominaga T, Wakata K, et al. Clinical significance of the C-reactive protein-to-albumin ratio for the prognosis of patients with esophageal squamous cell carcinoma. Mol Clin Oncol. 2018;8(2):370–374. doi:10.3892/mco.2017.152729435305
   PubMed Web of Science ®Google Scholar
• Kitagawa H, Namikawa T, Munekage M, et al. Preoperative patient-related factors associated with prognosis after esophagectomy for esophageal cancer. Esophagus. 2017;14(4):360–365. doi:10.1007/s10388-017-0586-4
   Web of Science ®Google Scholar
• Fang Y, Xu C, Wu P, et al. Prognostic role of C-reactive protein in patients with nasopharyngeal carcinoma: a meta-analysis and literature review. Medicine (Baltimore). 2017;96(45):e8463. doi:10.1097/MD.000000000000846329137033
   PubMed Web of Science ®Google Scholar
• Lim WS, Roh JL, Kim SB, Choi SH, Nam SY, Kim SY. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma. Laryngoscope. 2017;127(12):E437–E442. doi:10.1002/lary.2669128561532
   PubMed Web of Science ®Google Scholar
• Ayhan A, Günakan E, Alyazıcı İ, Haberal N, Altundağ Ö, Dursun P. The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer. Arch Gynecol Obstet. 2017;296(5):989–995. doi:10.1007/s00404-017-4511-928875365
   PubMed Web of Science ®Google Scholar
• Shim SR, Kim SJ, Kim SI, Cho DS. Prognostic value of the Glasgow prognostic score in renal cell carcinoma: a meta-analysis. World J Urol. 2017;35(5):771–780. doi:10.1007/s00345-016-1940-127665441
   PubMed Web of Science ®Google Scholar
• Li MX, Bi XY, Li ZY, et al. Prognostic role of Glasgow prognostic score in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94(49):e2133. doi:10.1097/MD.000000000000087426656342
   PubMed Web of Science ®Google Scholar
• Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis. Sci Rep. 2017;7(1):16717. doi:10.1038/s41598-017-16955-529196718
   PubMed Web of Science ®Google Scholar
• McMillan DC. The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–540. doi:10.1016/j.ctrv.2012.08.00322995477
   PubMed Web of Science ®Google Scholar
• Zhao X, Xu Z, Li H. NSAIDs use and reduced metastasis in cancer patients: results from a meta-analysis. Sci Rep. 2017;7(1):1875 Epub 2017 May 14. doi:10.1038/s41598-017-01644-028500305
   PubMedGoogle Scholar